Total Funding
35
Total FundingSeed raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
215808
Inositec is a biotech company that develops a treatment for soft tissue calcification disorders.
Mattias Ivarsson: CEO and founder
Roberto Maj: Head of DevelopmentPast Role: Telormedix, Founder & Head of Drug Development
About the Company
Inositec is a biotech company that develops a treatment for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs. Its lead programs address vascular and renal calcification disorders, including orphan indications.
The company was founded in 2015 as a spin-off of ETH Zurich.
